Envestnet Asset Management »

G1 Therapeutics shares owned by Envestnet Asset Management

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Envestnet Asset Management from 13F filings

Historical chart of Envestnet Asset Management investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Envestnet Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Envestnet Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $153k 35k 4.32
2023-09-30 $35k 24k 1.44
2023-06-30 $50k 20k 2.49
2023-03-31 $44k 16k 2.68
2022-12-31 $56k 10k 5.43
2022-06-30 $53k 11k 4.92

More positions owned by Envestnet Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Envestnet Asset Management

Top funds holding G1 Therapeutics

Vanguard Group
Susquehanna International
Renaissance Technologies
Raymond James & Associates
D. E. Shaw & Co
BlackRock
Geode Capital Management
Goldman Sachs Group
Millennium Management
Acadian Asset Management
Standard Life Aberdeen
Connor, Clark & Lunn Investment Management
HAP Trading
Bank of America Corporation
Jacobs Levy Equity Management

View all funds holding G1 Therapeutics